Article Text

Download PDFPDF

Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al
Free
  1. Johannes Knitza1,
  2. Lorenzo Cavagna2,
  3. Georg Schett1,
  4. Jörg H W Distler1
  1. 1 Department of Internal Medicine 3, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  2. 2 Department of Rheumatology, University and IRCCS Foundation Policlinico S. Matteo, Pavia, Italy
  1. Correspondence to Dr Johannes Knitza, Department of Internal Medicine 3, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen D-91054, Germany; johannes.knitza{at}uk-erlangen.de

Statistics from Altmetric.com

With great interest, we read the letter titled ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al 1 published in the Annals of the Rheumatic Diseases.

The authors analysed if the detection of anti-aminoacyl transfer RNA synthetase (ARS) autoantibodies other than anti-Jo1 could improve the European League Against Rheumatism/Amercian College of Rheumatology (EULAR/ACR) classification criteria2 for adult and juvenile idiopathic inflammatory …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles